21101-79-1

Usage

Uses

Used in Pharmaceutical Research:
2-(Ethylthio)benzoic acid is used as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable component in the development of new drugs and chemical compounds.
Used in Organic Synthesis:
2-(Ethylthio)benzoic acid is used as a key intermediate in organic synthesis, allowing for the creation of a wide range of chemical products. Its versatility and reactivity make it an essential component in the synthesis of various organic compounds.
Used in Anti-inflammatory Applications:
2-(Ethylthio)benzoic acid has been studied for its potential anti-inflammatory properties, making it a candidate for use in the development of anti-inflammatory medications and treatments.
Used in Analgesic Applications:
Due to its potential analgesic properties, 2-(ethylthio)benzoic acid may be utilized in the development of pain-relief medications and therapies, providing an alternative to existing analgesics.

InChI:InChI=1/C9H10O2S/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H,10,11)

Upstream product

• 109-72-8 n-butyllithium 
• 60-29-7 diethyl ether 
• 622-38-8 Ethyl phenyl sulfide 
• 64-67-5 diethyl sulfate 
• 140-89-6 potassium ethyl xanthogenate 
• 118-92-3 anthranilic acid 
• 74-96-4 ethyl bromide 
• 147-93-3 Thiosalicylic acid 
• 546-74-7 sodium ethyl sulfate 
• 3795-78-6 2-ethylsulfanyl-benzoic acid methyl ester 
• 4892-02-8 Methyl thiosalicylate 
• 100-68-5 methyl-phenyl-thioether 
• 75-03-6 ethyl iodide 
• 16671-86-6 2-thiocyanatobenzoic acid 

Downstream Products

• 100058-70-6 Ethyl 2-(ethylthio)benzoate 
• 23010-33-5 1-(chloromethyl)-2-(ethylsulfanyl)benzene 
• 37527-80-3 (2-Ethanesulfinyl-phenyl)-acetic acid methyl ester 
• 37527-76-7 (2-ethylsulfanyl-phenyl)-acetic acid methyl ester 
• 37527-72-3 2-Ethylthiobenzylcyanid 
• 37527-74-5 2-Ethylthiophenylessigsaeure 
• 892388-62-4 tert-butyl (3S)-3-{[2-(ethylthio)benzoyl]amino}pyrrolidine-1-carboxylate 
• 207512-62-7 trans-2-ethylthiobenzoatobis(triphenylphosphine)phenylpalladium(II) 
• 492-22-8 thio-xanthene-9-one 
• 1527-13-5 2-Phenylthiobenzoesaeureethylester 
• 173312-15-7 2-ethylsulfanyl benzoic acid chloride 
• 5651-50-3 2-methyl-4H-benzo[d][1,3]oxathiin-4-one 
• 161058-27-1 2-ethylsulfonylbenzoic acid 

Relevant academic research and scientific papers

Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold

A large library of derivatives based on the scaffold of 2-(benzylsulfinyl)benzoic acid were synthesised and tested as atypical inhibitors against four different isoforms of human carbonic anhydrase (hCA I, II, IX and XII, EC 4.2.1.1). The exploration of the chemical space around the main functional groups led to the discovery of selective hCA IX inhibitors in the micromolar/nanomolar range, thus establishing robust structure-activity relationships within this versatile scaffold. HPLC separation of some selected chiral compounds and biological evaluation of the corresponding enantiomers was performed along with molecular modelling studies on the most active derivatives.

DNA binding and antitumor activities of platinum(IV) and zinc(II) complexes with some S-alkyl derivatives of thiosalicylic acid

A series of complexes of platinum(IV) (C1–C5) and zinc(II) (C6–C10) with S-alkyl derivatives of thiosalicylic acid were prepared and characterized. The interactions of the complexes with calf thymus DNA were analyzed by absorption (UV–Vis) and emission spectral studies (ethidium bromide displacement studies). The cytotoxic activities of complexes C1–C10 were determined against mouse B cell lymphocytic leukemia cells (BCL1), human B-prolymphocytic leukemia (JVM-13), mouse mammary carcinoma cells (4T1), and human mammary carcinoma cells (MDA-MB-468) and compared to the activities of the free ligand precursors and cisplatin. The cytotoxicities of the platinum(IV) and zinc(II) complexes toward mouse tumor cell lines were higher compared with their effects on human tumor cell lines. The zinc(II) complex C9 showed the highest antitumor activity toward the tested human cell lines, while the platinum(IV) complex C4 exhibited the highest antitumor activity toward mouse BCL1 and 4T1 cells. Both C4 and C9 have ligands derived from S-propyl thiosalicylic acid.

PIPERAZINYL METHANONE NAAA INHIBITORS

Disclosed herein, inter alia, are compositions and methods for modulating the activity of N-acylethanolamine acid amidase for the treatment of a pathological state, including pain, an inflammatory condition, or a neurodegenerative disorder.

New piperazine derivatives having anti-cancer effect, combination therapeutic effect with radiation, and anti-diabetic effect, and PPAR activity, and medical use thereof

The present invention relates to a novel piperazine derivative having an anti-cancer effect, a combination therapeutic effect with radiation, and an anti-diabetic effect, and to a medical use thereof. The piperazine derivatives are PPAR-γ ligand, and have

Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis

Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are endogenous lipid mediators that suppress inflammation. Their actions are terminated by the intracellular cysteine amidase, N-acylethanolamine acid amidase (NAAA). Even though NAAA may offer a new target for anti-inflammatory therapy, the lipid-like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs. A series of novel benzothiazole–piperazine derivatives that inhibit NAAA in a potent and selective manner by a non-covalent mechanism are described. A prototype member of this class (8) displays high oral bioavailability, access to the central nervous system (CNS), and strong activity in a mouse model of multiple sclerosis (MS). This compound exemplifies a second generation of non-covalent NAAA inhibitors that may be useful in the treatment of MS and other chronic CNS disorders.

Cytotoxicity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-ethyl derivative of thiosalicylic acid

The spectroscopically predicted structure of the obtained copper(II)-complex with S-ethyl derivative of thiosalicylic acid was confirmed by X-ray structural study and compared to previously reported crystal structure of the Cu complex with S-methyl deriva

Cytotoxicity of palladium(II) complexes with some alkyl derivates of thiosalicylic acid. Crystal structure of the bis(S-butyl-thiosalicylate)palladium(II) complex, [Pd(S-bu-thiosal)2]

The spectroscopically predicted structure of the obtained bis(S-butyl-thiosalicylate)palladium(II) complex, [Pd(S-bu-thiosal)2], was confirmed by an X-ray structural study. The asymmetric unit of [Pd(S-bu-thiosal)2] consists of neutr

Synthesis, characterization and antimicrobial activity of copper(II) complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II) complex with S-methyl derivative of thiosalicylic acid

The five new copper(II) complexes with some S-alkyl derivatives of thiosalicylic acid (alkyl = benzyl (L1), methyl (L2), ethyl (L3), propyl (L4), butyl (L5)) have been synthesized and characterized by microanalysis and infrared spectra. The spectroscopica

Synthesis, characterization and antimicrobial activity of palladium(II) complexes with some alkyl derivates of thiosalicylic acids: Crystal structure of the bis(S-benzyl-thiosalicylate)-palladium(II) complex, [Pd(S-bz-thiosal) 2]

S-Alkyl (R = benzyl, methyl, ethyl, propyl and butyl) derivatives of thiosalicylic acid and the corresponding palladium(II) complexes were prepared and their structures were proposed on the basis of infrared, 1H and 13C NMR spectrosc

Synthesis, spectral characterization and electrochemical properties of (2-alkylthiobenzoyl)ferrocenes. Crystal structures of 2-methylthio, 2-ethylthio and 2-isopropylthio derivatives

The one-pot synthesis of seven new (2-alkylthiobenzoyl)ferrocenes has been achieved by Friedel-Crafts acylation of ferrocene with acid chlorides generated in situ from the corresponding carboxylic acids and phosphorous trichloride. The obtained compounds